Lv6
2938 积分 2024-08-03 加入
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy
27天前
已完结
Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia
1个月前
已完结
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
1个月前
已完结
Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)
1个月前
已完结
Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease
2个月前
已完结
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
3个月前
已完结
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
5个月前
已完结
Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia
5个月前
已完结
Hyperkalemia Recurrence Following Medical Nutrition Therapy in Patients with Stage 3–4 Chronic Kidney Disease: The REVOLUTIONIZE I Real-World Study
6个月前
已完结
Effects of Roxadustat on Thyroid Profiles in Patients and Animals with Chronic Kidney Disease
8个月前
已完结
皖公网安备34019202002308
